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ABSTRACT 
By way of appending the C2-symmetric carbocyclic cleft diol with thiocarbamates with 
varying substituents, significant control of the hydrogen bonded network can be achieved. 
Smaller alkyl substituents lead to the formation of stacked columns of components with the 
apex of one molecule suitably aligned in the cleft of a second. Aryl substituents however, 
lead to the formation of ribbons via an H-bonding network. Additionally, the packing of these 
ribbons into networks is considerably different between the enantiopure and racemic clefts, 
with the latter giving rise to channels within the crystal structure. 
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INTRODUCTION 
The carbocyclic diol cleft molecule 1
1-3 has become a surrogate for Tröger’s base (2) in 
catalysis,
4
 supramolecular chemistry
5-7
 and chiral recognition (figure 1).
8-11
 It is analogous to 
Tröger’s base as it contains a C2-symmetric axis, a chiral cavity with a defined geometry and 
a rigid, predictable structure. This give 1 a predictable V-shape, whose angle (θ) can vary 
between 83.4˚ to 104.3˚ depending on the substitution on the aromatic ring.12,13 The 
advantages of 1 over Tröger’s base lie in the diol, with the two hydroxyl groups being 
pointed into the interior of the cleft giving the ability, via hydrogen bonding, to orientate and 
organize substrates into this uniquely chiral cavity. We have previously emphasized the 
practicality of 1 by appending the hydroxyl groups with pyridyl functionality, as well as 
highlighting the self-assembly of these pyridyl adducts with phenylboronic acid to yield bis-
boroxine substrates, with the 4-pyridyl analogue being fully characterized by single crystal 
X-ray analysis emphasizing the chiral space.
14,15
 
Figure 1. The C2-centrosymmetric chiral cleft diol 1. 
 
The capacity to be able to confidently predict crystal packing to facilitate the design of new 
solids with sought after physical properties has been central to the evolution of crystal 
engineering.
16-18
 Furthermore, the ability to control secondary and tertiary structure within 
crystal packing has enormous potential in the development of new functional materials and 
devices. Molecular tectonics
19-22
 is the analysis of molecular crystals and their subsequent 
formation of networks, and as a consequence the tecton is defined as a construction unit with 
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defined structural and energetic attributes that can control assembly via programmed 
molecular recognition processes.  Consequently, the identification of new 3-dimensional 
chiral molecules, or tectons, with rigid, predictable structures opens further prospects in 
expanding the scope of crystal engineering. 
Akin to Troger’s base (2),23,24 diol 1 can  pack, in the solid state, in four possible forms M1, 
M2, M3 and M4, all of which are primarily driven by weak van der Waals, and π-π 
interactions (figure 2).
25
 
Figure 2. Control of crystal packing in chiral cleft diol 1. 
 
Conversely, thiocarbamates (3) like amides, form networks based on stronger hydrogen 
bonding, which is, in part, controlled by their configuration, with the cisoid form 3a leading 
to synthon 4, and the transoid form 3b leading to synthon 5 (scheme 1).
26,27
 
 
Scheme 1. Control of crystal packing in thiocarbamate 3. 
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In an effort to regulate the crystal packing of chiral cleft 1, we envisaged appending the diol 
with a variety of thiocarbamates (alkyl and aryl, scheme 2, 6). The crystal packing of these 
derivatives would then be primarily defined by the orientation of the thiocarbamate (cisoid 
and/or transoid) that is accurately described by 6a ↔ 6b ↔ 6c. This would serve two 
purposes: (a) to allow the confident prediction of the crystal packing of 6, therefore 
demonstrating this scaffold as a potential tecton; (b) to demonstrate that novel crystalline 
solids with predictable chiral environments can be formed from analogues of 1. 
 
Scheme 2. Targeted thiocarbamates. 
 
RESULTS AND DISCUSSION 
Preparation of thiocarbamate appended clefts 
The synthesis of the thiocarbamate cleft derivatives began with obtaining multi-gram 
quantities of the parent cleft diol 1, and this was achieved as reported previously (scheme 3).
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This racemic diol could then be converted to the bis-thiocarbamate by treatment with NaH 
and excess isothiocyanate. This was accomplished with phenyl, tolyl, 3,5-
ditrifluromethylphenyl, methyl, and butyl isothiocyanates giving the desired compounds (±)-
10a-e in moderate to good yields. In addition to the racemic thiocarbamates, enantiopure tolyl 
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thiocarbamate was also prepared (scheme 3). This was achieved by synthesizing the 
enantiopure di-acid (+)-8 via resolution of its racemate with quinine. This enantiopure diacid 
was then converted to the thiocarbamate, delivering enantiopure (+)-10b. 
 
Scheme 3. Preparation of thiocarbamates (±)-10a-e and (+)-10b. 
X-ray crystallographic analysis 
Single crystal X-ray analysis was performed on phenyl (±)-10a, tolyl (±)-10b, 3,5-
ditrifluromethylphenyl (±)-10c, methyl (±)-10d, and butyl (±)-10e thiocarbamates. 
Additionally, single crystal X-analysis was also performed on the enantiopure tolyl (+)-10b 
analogue as a comparison with its racemic analogue. Crystal data, H-bond geometry, and 
50% ORTEP plots are presented in the SI, and crystallographic procedures are described in 
the experimental section.
28
 
The crystal structure of the racemic phenyl-amino-thiocarbamate cleft (±)-10a illustrates the 
rigid cleft framework and the position of the two appending phenyl-amino-thiocarbamate 
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units that are orientated towards the interior of the cleft.
28
 Interestingly the sulfur and 
thiocarbamate N–H groups are pointing outwards away from the cleft cavity such that only 
the aromatic phenyl groups are directed inwards towards the cleft. Molecules of (±)-10a were 
shown to interact with each other according to the packing plot shown in figure 3(a). Thus, 
molecules of (±)-10a are linked together in a 1D polymeric H-bonded chain with amino-
thiocarbamate groups forming pairs of R
2
2(8), centro-symmetric N–H···S H-bond 
interactions to neighboring molecules.
26,27,29 
Figure 3. X-ray analysis and the H-bonded chain of (±)-10a, (+)-10b and (±)-10b, 
respectively. 
(a) (±)-10a 
 
(b) (+)-10b 
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(c) (±)-10b 
 
The X-Ray crystal structure
30
 of the (+)-enantiomer of the p-tolyl-amino-thiocarbamate cleft 
(+)-10b, shows that the substituted amino-thiocarbamate groups are also directed into the 
cavity of the cleft bicycle with the thiocarbamate sulfur and N–H groups pointing outwards 
away from the center of the cavity.
28
 Molecules of (+)-10b were bound to each other by a 
very similar H-bonding network as displayed in the crystal structure of (±)-10a. Thus 
molecules are linked together via pairs of R
2
2(8), centro-symmetric N–H···S H-bonds 
forming chains of molecules (figure 3(b)).
31
 Essentially the molecular structure of (±)-10b is 
exactly the same as the (+)-enantiomer with complexing p-tolyl-amino-thiocarbamate groups 
pointing into the cavity of the cleft bicycle and both the N–H and sulfur groups of the 
appending amino-thiocarbamate groups pointing away from the interior of the cavity.
30
 Like 
in (+)-10b, this arrangement of functional groups allowed molecules to form chains linked by 
pairs of R
2
2(8), centro-symmetric N–H···S H-bonds (figure 3(c)).
32
 
However, unlike the crystal structure of (+)-10b, which was found to contain 
crystallographically independent molecules with no solvent of crystallization, the crystal 
structure of the racemic compound (±)-10b contained solvate molecules of methanol which 
lie disordered over a two-fold axis exo- to the cleft molecules. In addition, an acetonitrile 
solvate molecule bound via a pair of C–H···π interactions resides in the cleft cavity (figures 
3c and 4b). Interestingly, because the cleft cavity is occupied with solvent molecules bound 
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to the cleft by moderate C–H···π interactions, neighboring H-bonded chains made up of 
molecules of (±)-10b are unable to interact as they did in (+)-10b where the terminal p-tolyl 
group from one chain penetrates into the cavity of the molecule in the next chain forming an 
‘above / below’ type packing pattern (type M2 figure 4(a)). Instead chains of H-bonded 
molecules arrange into groups of six molecules which interact to form rings with the internal 
clefts filled with acetonitrile solvate molecules (figure 4(b)). 
Figure 4. Comparison of the packing pattern of enantiopure and racemic 10b, both of which 
illustrate M2-type pack of the C2-centrosymmetric cleft. 
(a) (+)-10b 
 
(b) (±)-10b 
 
In the crystal structure of (±)-10c, the fluorine atoms which make up the CF3 groups were 
modeled as split over two sets of positions with one of the C6H3CF3 groups
28
 showing the 
potential to be more disordered than the others.
33
 Like the other N-aryl functionalized amino-
thiocarbamate clefts the Ph(CF3)2 substituted amino-thiocarbamate groups in (±)-10c are 
directed into the cleft cavity with the thiocarbamate sulfur and N–H groups directed away 
from the interior of the cleft. It would appear from X-Ray packing plots that the bulky 
pendant fluorinated aromatic groups block the cleft cavity, preventing any interactions 
between the π-systems of neighboring cleft molecules. As a result, the only significant non-
 9 
covalent interactions observed are H-bonds in (±)-10c between the thiocarbamate N–H 
groups and the sulfur atom of a neighboring molecule resulting in a 2-dimentional H-bonded 
sheet via one R
2
2(8), centro-symmetric motif and several chain linkages (figure 5).  
Figure 5. X-ray H-bonding analysis of (±)-10c. The 3,5-ditrifluoromethylphenyl groups have 
been omitted for clarity. 
 
The length of the H-bonds between the sulfur and N–H groups34 are very similar to those 
observed in (+)-10b and (±)-10b, however the overall packing pattern displayed in this 
structure is considerably more complex due to the fluoroaryl groups. 
As in the p-tolyl, phenyl and fluoroaryl substituted amino-thiocarbamate groups the 
appending methyl-thiocarbamate groups of (±)-10d
30 
are directed into the cavity of the 
cleft.
28
 However, unlike the N-aryl substituted thiocarbamate clefts mentioned previously, the 
thiocarbamate N–H groups in (±)-10d are shown to be directed into the cavity of the cleft; 
presumably the less bulky methyl groups facilitate this orientation. This removes the ability 
of the thiocarbamate N–H groups to form centro-symmetric H-bonds with neighboring clefts, 
as demonstrated by the clefts (+)-10b and (±)-10b (figures 3 and 4), which appears to 
influence the way in which molecules of (±)-10d interact with each other. The packing 
pattern displayed by (±)-10d showed that molecules are linked via N–H···S H-bonds into 
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chains / ladders, thus the apex of one molecule is accommodated in the cleft of the next to 
form columns of apex-to-base stacked molecules, like a stack of party hats (type M1).
35
 The 
two hydrogens in the CH2 at the bridgehead of the cleft at C(9); C(30) and C(51) (figure 6(a)) 
make up pairs of C–H···π interactions with the cleft of the molecule ‘above’.36 In addition to 
this molecular stacking pattern, this cleft presents a highly unusual cooperative packing 
system, where each group of three molecules is H-bonded to the next group of three 
molecules but with a 180° rotation between one group and the next.
37
  
Weakly diffracting crystals of (±)-10e were obtained and analyzed using synchrotron 
radiation.
28,30 
There were difficulties in uniquely identifying the space group which are 
described in the experimental section. Despite these problems the identification of the 
compound and the nature of the stacking was clearly established (figure 6(b)). The stacking 
adopted is the same M1 motif adopted by the methyl analog (±)-10d. 
Figure 6. X-ray analysis of (±)-10d and (±)-10e, respectively illustrating the H-bonded 
ladder network. 
(a) (±)-10d 
 
(b) (±)-10e 
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From the X-ray data it is clear that the size of the R group on the thiocarbamate effects the 
orientation and packing of the cleft. In the case of the R being alkyl (methyl or 
n
butyl) both 
the thiocarbamates take on the cisoid conformation (scheme 4, 6a) and this promotes synthon 
4 giving (±)-11d and (±)-11e, respectively. This is further reinforced by weak, non-bonding 
interactions forming columns of two or more components with the apex of one molecule 
suitably aligned in the cleft of a second, and can be defined as M1 type packing.   
 
Scheme 4. The role of the thiocarbamate in determining crystal structure and the H-bonded 
network. 
However, when R is an aryl group the preferred conformation of the thiocarbamate is 
transoid (6c) which promotes synthon 5 giving ribbons of clefts within the crystal structures 
(±)-11a,b and (+)-11b. The packing of these ribbons in the enantiopure clefts (+)-11b is then 
M1
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R (  ) = 
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controlled by the insertion of an aryl group of one cleft into the cleft of another via endo-face 
to endo-face interactions, and can be defined as M2 type packing. In contrast, in the racemic 
series (±)-11a,b the packing of these ribbons gives rise to a new motif M5, which promotes 
the formation of rings with the internal clefts filled with acetonitrile solvate molecules. 
Clearly this latter network provides the opportunity to form other host:guest complexes using 
these channels. Finally, the 3,5-CF3Ph thiocarbamate (±)-10c, which contains bulky pendant 
fluorinated aromatic groups that block the cleft cavity, presumably forms networks using the 
cisoid (6a), transoid (6c) or mixtures of both forms (6b), giving a disordered H-bonded 
network. 
CONCLUSIONS 
Through using a combination of a novel chiral cleft molecule and thiocarbamates we have 
demonstrated that we can control the crystal packing by simple variation of the size of the 
substituent on the thiocarbamate. This has been achieved due to the tendency of the C2-
symmetric cleft to form molecule associations within the solid state described as M1–M4, 
and thiocarbamates to form synthons via their cisoid and transoid conformers. Smaller 
substituents lead to H-bonding in the thiocarbamate in its cisoid form, and this is further 
strengthened by type M1 interactions. Larger substituents such as phenyl and tolyl lead to H-
bonding ribbon type networks via the transoid form of the thiocarbamate. However, we have 
demonstrated that the packing of these ribbons differs significant between the racemic and 
enantiopure clefts, with the racemic series giving rise to channels within the crystal structure, 
via a new type of interaction M5. Moreover, the crystal structure of (±)-10b provided 
evidence of the ability of these novel amino-thiocarbamate clefts to bind guest molecules 
with complementary size and binding features. Interestingly, binding within the cleft cavity 
was facilitated by C–H···π H-bond interactions originating from the core carbocyclic cleft 
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framework, and not by H-bonds involving the thiocarbamate groups. Given that cleft 1 is C2-
symmetric, this simple but effective control of crystallization within the solid state has 
significant potential to be expanded upon using other hydrogen bond synthons.  
EXPERIMENTAL 
General Procedure for the Preparation of Amino-thiocarbamate Clefts. Sodium hydride 
(60 % mineral oil, 4.0 mmol) was washed with hexane (3 x 10 mL) and dried under vacuum, 
THF (10 mL) was added and the suspension was cooled to 0
o
C. Racemic (±)-1 or (+)-1 (1.0 
mmol) was dissolved in THF (5 mL) and added to the sodium hydride suspension via a 
cannula under nitrogen and the reaction was stirred at 0
o
C for 25 min. After this time a 
solution of substituted isothiocyanate (3.0 mmol) in THF (5 mL) was added dropwise to the 
reaction mixture. The solution was allowed to warm to room temperature and then stirred for 
a further 18 h; reactions were monitored by TLC. After this time the reaction was quenched 
by the careful addition of water (20 mL) and extracted with dichloromethane (3 x 25 mL). 
The combined organic layers were washed with brine (25 mL), dried over MgSO4, filtered 
and concentrated to dryness in vacuo. The crude compound was purified by silica column 
chromatography. 
(±)-2,8-Dibenzobicyclo [b,f] [3.3.1]nona-5a, 6a-dien-6,12-phenyl amino thiocarbamate 
(±)-10a. (0.2 g, 57 %), fine white solid; Mp 111.6 – 114.7 oC; 1H NMR (400 MHz, CDCl3): δ 
7.74 – 7.00 (m, 20 H), 3.91 – 3.88 (m, 2H), 2.60 – 2.58 (m, 2H); 13C NMR (100 MHz, 
CDCl3): δ 188.41, 136.86, 136.65, 134.61, 133.96, 130.67, 130.48, 129.04, 127.66, 127.47, 
126.77, 125.26, 121.42, 83.74, 72.59, 39.22, 35.62, 29.08; IR CH2Cl2 max/cm
–1
: 3943, 3584, 
3361 (N–H), 3054, 2986 (aromatics), 2305, 1526, 1265, 1160, 1034, 743, 705; HRMS m/z 
found 545.1327 C31H26O2N2S2 (M
+ 
Na) expected 545.1328 (M
+ 
Na); Elemental Analysis 
found C 71.06; H 4.98; N 5.41 % C31H26N2O2S2 requires C 71.24; H 5.01; N 5.36 %.  
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(±)-2,8-Dibenzobicyclo [b,f] [3.3.1]nona-5a, 6a-dien-6,12-p-tolyl amino thiocarbamate 
(±)-10b. (0.4 g, 70 %) fine white solid; Mp 209.9 – 211.2 oC; 1H NMR (400 MHz, CDCl3): δ 
7.58 (d, J = 8.4 Hz, 2H), 7.29 – 7.15 (m, 7H), 7.09 (d, J = 7.2 Hz, 2H), 7.04 – 6.84 (m, 7H), 
3.89 (m, 2H), 2.58 (m, 2H), 2.41 (s, 3H), 2.28 (s, 3H); 
13
C NMR (100 MHz, CDCl3): δ 
188.30, 136.32, 135.36, 134.92, 134.83,133.85, 131.05, 129.72, 129.54, 127.39, 127.11, 
126.55, 123.59, 121.47, 83.37, 79.45, 46.00, 35.36, 20.93; IR CH2Cl2 max/cm
–1
: 3944 (s, N–
H), 3689 (s, N–H), 2986 (aromatics), 2305, 1520, 1265, 739, 704; HRMS m/z found 
573.1639 C33H30O2N2S2 (M
+ 
Na) expected 573.1641 (M
+ 
Na); Elemental analysis found C 
71.55; H 5.46; N 5.13 %; C33H30N2O2S2 requires C 71.97; H 5.49; S 5.09 %.  
(+)-2,8-Dibenzobicyclo [b,f] [3.3.1]nona-5a, 6a-dien-6,12-p-tolyl amino thiocarbamate 
(+)-10b (0.26 g, 24 %), fine white solid; Mp 116.2 – 124.7 oC; [α]D
21
 + 174.3 (c 1.0, CHCl3); 
1
H NMR (400 MHz, CDCl3): δ 7.47 (d, J = 7.6 Hz, 2H), 7.17 – 7.08 (m, 7H), 6.95 (d, J = 5.2 
Hz, 2H), 6.89 – 6.75 (m, 7H), 3.79 (m, 2H), 2.46 (m, 2H), 2.30 (s, 3H), 2.14 (s, 3H); 13C 
NMR (100 MHz, CDCl3): δ 188.21, 136.36, 134.84, 134.30, 131.08, 129.61, 129.54, 127.14, 
126.56, 123.63, 121.52, 83.34, 79.44, 35.42, 28.82, 20.99; IR CH2Cl2 max/cm
–1
: 3944, 3054 
(N–H), 2986 (aromatics), 2305, 1522, 1265, 1171, 1034, 739, 704; HRMS m/z found 
573.1642 C33H30O2N2S2 (M
+ 
Na) expected 573.1641 (M
+ 
Na); Elemental analysis found C 
71.79; H 5.57; N 5.16 %; C33H30N2O2S2 requires C 71.97; H 5.49; N 5.09 %.  
(±)-2,8-Dibenzobicyclo [b,f] [3.3.1]nona-5a, 6a-dien-6,12-bis-3,5- bis (trifluoromethyl) 
phenyl amino thiocarbamate (±)-10c. (0.70 g, 44 %), off-white solid; Mp 120.1 – 127.4 oC; 
1
H NMR (400 MHz, CDCl3): δ 8.00 – 6.20 (m, 14H), 3.85 (s, 2H), 1.44 (s, 2H; 
13
C NMR 
(100 MHz, CDCl3): δ 194.42, 140.05, 134.52, 128.85, 138.83, 128.79, 128.30, 48.82, 32.33; 
IR CH2Cl2 max/cm
–1
: 3204, 3055 (N–H), 2987 (aromatics), 2306, 1551, 1139, 1265, 1031, 
738, 703; HRMS m/z found 817.0777 C35H22O2N2S2F12 (M
+ 
Na) expected 817.0823 (M
+ 
Na); 
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Elemental analysis found C 52.34; H 2.77; N 3.72 % C35H22F12N2O2S2 requires C 52.90; H 
2.79; N 3.53 %.  
(±)-2,8-Dibenzobicyclo [b,f] [3.3.1]nona-5a, 6a-dien-6,12-methyl amino thiocarbamate 
(±)-10d. (0.60 g, 75 %), colorless solid; Mp 212.1 – 218.2 oC; 1H NMR (400 MHz, CDCl3): δ 
7.12 – 7.04 (m, 8H), 6.79 (dd, J = 6.8 Hz, 1H), 6.35 (dd, J = 6.0 Hz, 1H), 3.74 (m, 1H), 3.66 
(m, 1H), 3.13 (t, J = 5.2 Hz, 6H) 2.64 (d, J = 5.2 Hz, 1H), 2.53 (d, J = 5.2 Hz, 1H), 1.97 (m, 
2H); 
13
C NMR (100 MHz, CDCl3): δ 194.1 90.09, 135.52, 135.43, 135.26, 134.88, 130.98, 
127.36, 127.31, 127.20, 126.99, 126.81, 126.77, 126.71; IR CH2Cl2 max/cm
–1
: 3399 (N–H), 
3052 (aromatics),1528, 1265, 1068, 737, 703; HRMS m/z found 421.1013 C21H22O2N2S2 (M
+ 
Na) expected 421.1015 (M
+ 
Na); Elemental analysis found C 63.07; H 5.58; N 6.99 % 
C21H22N2O2S2 requires C 63.29; H 5.56; N 7.03 %. 
 (±)-2,8-Dibenzobicyclo [b,f] [3.3.1]nona-5a, 6a-dien-butyl amino thiocarbamate (±)-10e. 
(0.19 g, 20 %), colorless solid; Mp 213.3 – 214.4 oC; 1H NMR (400 MHz, CDCl3): δ 7.46 – 
6.70 (m, 12H), 5.01 (m, 2H), 3.74 (s, 1H), 3.31 (s, 1H), 2.49 – 2.36 (m, 2H), 2.25 (S, 3H); 
13
C NMR (100 MHz, CDCl3): δ 188.51, 130.59, 129.56, 127.63, 127.44, 126.73, 121.50, 
83.63, 72.60, 39.22, 35.61, 29.09, 21.31; IR CH2Cl2 max/cm
–1
: 3257 (N–H), 2957, 2931 
(aromatics), 1519, 1179, 1038, 752; HRMS m/z found 505.1954 C27H34O2N2S2 (M
+ 
Na) 
expected 505.1954 (M
+ 
Na); Elemental analysis found C 66.96; H 7.02; N 5.73 % 
C25H23NO2S requires C 67.18; H 7.10; N 5.80 %. 
X-ray Crystallography 
Diffraction data for (±)-10a·CHCl3 and (±)-10b·MeOH·CH3CN, and were collected on a 
Bruker APEX 2 CCD diffractometer equipped with graphite-monochromated Mo-Kα X-
radiation. Diffraction data for (+)-10b, (±)-10c·0.25C5H12, and (±)-10d and were collected on 
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a Bruker APEX 2 CCD diffractometer equipped with a silicon 111 monochromator using 
narrow frame ω-scans on Station 11.3.1 at the ALS using synchrotron radiation.38 Data for 
(±)-10e were also collected at the ALS but with a Bruker D8 diffractometer with a CMOS 
detector using shutterless ω-scans. Data were corrected for absorption and Lp effects.38 
Structures were solved by direct methods or charge flipping algorithms
39,40 
and refined by 
full-matrix least squares on F
2
.
41
 Further details are given in Table 7 in the ESI. In (±)-
10a·CHCl3 the CHCl3 molecule was modeled as disordered over two sets of positions with 
major component 63.6(6)%. In (±)-10b·MeOH·CH3CN the MeOH molecule is disordered 
over a 2-fold axis and the OH position could not be reliably determined, so was not refined. 
In (±)-10c·0.25C5H12 there are two cleft molecules in the asymmetric unit, both exhibiting 
disorder. CF3 groups at C(26), C(34), C(35), C(69) and C(70) were all modeled as two-fold 
disordered, as were the ring atoms C(54) > C(57) and the CF3 group at C(60). The badly 
disordered partial pentane of crystallization was modeled as a diffuse area of electron density 
by the Platon Squeeze procedure.
42
 The structure of (±)-10e is presented as provisional due to 
the severe crystallographic problems encountered associated with space group ambiguity. 
Data sets were collected both in the home laboratory and at the ALS synchrotron. In both 
cases the same unit cell parameters were obtained. Crystal data for (±)-10e: C27H34N2O2S2, 
M = 482.68, monoclinic, Pc (or P21/c), a = 12.2150(11), b = 26.553(2), c = 24.029(2)Å, β = 
99.357(5)
o
, V = 7690.0(11) Å
3
, Z = 12, μ = 0.234 mm–1, 77800 reflections measured, 25961 
unique, Rint = 0.0749, R1[F
2>2σ(F2)] = 0.2110. Similarity restraints were applied to the 
geometry of all molecules and global restraints were required for anisotropic displacement 
parameters. Six molecules in the asymmetric unit in two groups of three for space group Pc, 
which gave the best result (one group of three in space group P21/c). N–H···S H-bonds in the 
range 3.28(2) – 3.541(13) Å and C–H···π distances in the range 2.41 – 2.75 Å.  
ASSOCIATED CONTENT 
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Supporting Information 
The Supporting Information is available free of charge on the ACS Publications website. 
Experimental procedures for the synthesis of (+)-9, (-)-9, (±)-9, as well as the HPLC traces of 
(+)-9, (-)-9 and (±)-9.  Spectroscopic data for all reported compounds. Table S1 contains the 
crystallographic data for (±)-10a, (+)-10b, (±)-10b, (±)-10c and (±)-10d. Tables S2-S7 
contain selected H-bonded geometries for (±)-10a, (+)-10b, (±)-10b, (±)-10c and (±)-10d, 
respectively. Figures S1-S6 contains ORTEP plots of (±)-10a, (+)-10b, (±)-10b, (±)-10c and 
(±)-10d (two molecules), respectively. Figure S7 depicts the H-bonding network of (±)-10c, 
and Figure S8 the H-bonding network of (±)-10e. 
Accession Codes 
CCDC 1441482-1441486 contains the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge Crystallographic Data Centre 
via www.ccdc.cam.ac.uk/data_request/cif, or by emailing data_request@ccdc.cam.ac.uk, or 
by contacting The Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge 
CB2 1EZ, UK; fax: +44 1223 336033. 
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By appending the C2-symmetric carbocyclic cleft diol, an analogue of Trögers base, with 
thiocarbamates with varying substituents (both alkyl and aryl) gives significant control of the 
H-bonded network. This leads to unique solid-state structures that have been fully 
characterized by crystallographic analysis. Additionally, a new type of intermolecular 
stacking interaction of the carbocyclic cleft molecules (M5), has been observed. 
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